Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sterry

Showing results (241-250 of 329) with videos related to

Pageof 33
Sort By:
European Journal of Applied Physiology|January 25, 2012
The influence of endurance exercise on the antioxidative status of human skinH B Vierck, M E Darvin, J Lademann, et al.
Journal of Cutaneous Pathology|August 1, 1996
T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skinN Potoczna, W H Boehncke, F O Nestle, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
No evidence of skin infection with Chlamydia pneumoniae in patients with cutaneous T cell lymphomaM J Rössler, G Rappl, M Muche, et al.
Genes and Immunity|June 18, 2004
Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpartB Weiss, K Wolk, B H Grünberg, et al.
Blood|November 10, 1998
Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and IIR Stadler, H G Otte, T Luger, et al.
Human Immunology|August 1, 1994
Analysis of TAP2 and HLA-DP gene polymorphism in psoriasisJ W Fakler, M Schmitt-Egenolf, S Vejbaesya, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2005
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiencesJ Bohmeyer, R Stadler, A Kremer, et al.
Archives of Dermatological Research|January 28, 1998
Influence of monomethylfumarate on monocytic cytokine formation--explanation for adverse and therapeutic effects in psoriasis?K Asadullah, H Schmid, M Friedrich, et al.
The British Journal of Dermatology|July 27, 1999
A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpressionK Asadullah, S Prösch, H Audring, et al.
The British Journal of Dermatology|March 6, 2012
The tumour suppressor p53 is frequently nonfunctional in Sézary syndromeB Lamprecht, S Kreher, M Möbs, et al.
Pageof 33

Showing results (241-250 of 329) with videos related to

Sort By:
Pageof 33
European Journal of Applied Physiology|January 25, 2012
The influence of endurance exercise on the antioxidative status of human skinH B Vierck, M E Darvin, J Lademann, et al.
Journal of Cutaneous Pathology|August 1, 1996
T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skinN Potoczna, W H Boehncke, F O Nestle, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
No evidence of skin infection with Chlamydia pneumoniae in patients with cutaneous T cell lymphomaM J Rössler, G Rappl, M Muche, et al.
Genes and Immunity|June 18, 2004
Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpartB Weiss, K Wolk, B H Grünberg, et al.
Blood|November 10, 1998
Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and IIR Stadler, H G Otte, T Luger, et al.
Human Immunology|August 1, 1994
Analysis of TAP2 and HLA-DP gene polymorphism in psoriasisJ W Fakler, M Schmitt-Egenolf, S Vejbaesya, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2005
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiencesJ Bohmeyer, R Stadler, A Kremer, et al.
Archives of Dermatological Research|January 28, 1998
Influence of monomethylfumarate on monocytic cytokine formation--explanation for adverse and therapeutic effects in psoriasis?K Asadullah, H Schmid, M Friedrich, et al.
The British Journal of Dermatology|July 27, 1999
A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpressionK Asadullah, S Prösch, H Audring, et al.
The British Journal of Dermatology|March 6, 2012
The tumour suppressor p53 is frequently nonfunctional in Sézary syndromeB Lamprecht, S Kreher, M Möbs, et al.
Pageof 33